Reproducibility metrics for CRISPR screens
Reproducibility metrics for CRISPR screens
复制标题
DOI:
10.1101/2022.02.19.480892
复制
发表时间:
2022-02
期刊:
影响因子:
--
通讯作者:
Maximilian Billmann;Henry N. Ward;Michael Aregger;M. Costanzo;B. Andrews;Charles Boone;J. Moffat;C. Myers
中科院分区:
文献类型:
--
作者:
Maximilian Billmann;Henry N. Ward;Michael Aregger;M. Costanzo;B. Andrews;Charles Boone;J. Moffat;C. Myers
CRISPR screens are used extensively to systematically interrogate the phenotype-to-genotype problem. In contrast to early CRISPR screens, which defined core cell fitness genes, most current efforts now aim to identify context-specific phenotypes that differentiate a cell line, genetic background or condition of interest, such as a drug treatment. While CRISPR-related technologies have shown great promise and a fast pace of innovation, a better understanding of standards and methods for quality assessment of CRISPR screen results is crucial to guide technology development and application. Specifically, many commonly used metrics for quantifying screen quality do not accurately measure the reproducibility of context-specific hits. We highlight the importance of reporting reproducibility statistics that directly relate to the purpose of the screen and suggest the use of metrics that are sensitive to context-specific signal.